ArticleBlood2022

BMP2/SMAD pathway activation in JAK2/p53-mutant megakaryocyte/erythroid progenitors promotes leukemic transformation.

Bing Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.